Trometamol salt of fosfomycin (Monuril). Preliminary pharmacokinetic and clinical experience in the treatment of urinary tract infections in children. 1987

P Careddu, and M Borzani, and F Varotto, and L Garlaschi, and P Fontana

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females

Related Publications

P Careddu, and M Borzani, and F Varotto, and L Garlaschi, and P Fontana
January 1987, European urology,
P Careddu, and M Borzani, and F Varotto, and L Garlaschi, and P Fontana
August 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
P Careddu, and M Borzani, and F Varotto, and L Garlaschi, and P Fontana
January 1994, International journal of clinical pharmacology research,
P Careddu, and M Borzani, and F Varotto, and L Garlaschi, and P Fontana
January 1987, European urology,
P Careddu, and M Borzani, and F Varotto, and L Garlaschi, and P Fontana
June 1987, Pathologie-biologie,
P Careddu, and M Borzani, and F Varotto, and L Garlaschi, and P Fontana
January 1987, European urology,
P Careddu, and M Borzani, and F Varotto, and L Garlaschi, and P Fontana
January 1990, Chemotherapy,
P Careddu, and M Borzani, and F Varotto, and L Garlaschi, and P Fontana
June 2019, Transplantation,
P Careddu, and M Borzani, and F Varotto, and L Garlaschi, and P Fontana
November 2006, Enfermedades infecciosas y microbiologia clinica,
P Careddu, and M Borzani, and F Varotto, and L Garlaschi, and P Fontana
January 1987, European urology,
Copied contents to your clipboard!